Immunotherapy (University of Heidelberg)

N/A

Report date: 2022/12/29 12:33:15

Base Information

Drug NameImmunotherapy (University of Heidelberg)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Heidelberg
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Heidelberg
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A